Create Free Account By creating an account using any of the options above, you agree to theTerms of Use&Privacy Policy ABMDAbiomed, Inc. Stock Price & Overview 14.09K followers ABMD is defunctsince December 26, 2022. Summary ABMD Analysis ...
NASDAQ:ABMD实时已退市 381.020.230.06%2022-12-21 16:00:00 今开:380.78 昨收:380.79 今日区间:380.51-381.28 52周区间:219.84-381.99 成交量:2060.80万 成交额:785107.60万 市值:171.81亿 市盈率:64.95 贝塔系数: 每股收益: 盘前381.020.000.00%成交量0万2023-01-03 09:30...
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources...
公司介绍 证券简介 企业高级查询(新) 资产负债表 利润表 现金流量表 每股指标 财务分析 杜邦分析阿比奥梅德 (ABMD.O)+ 收藏 证券简介(阿比奥梅德) 导出到EXCEL 完整财报对比 证券代码 ABMD.O 证券名称 阿比奥梅德 ISIN代码 SEDOL代码 证券类型 美股 曾用名 上市时间 1987-07-01 上市国家/地区 美国 上市...
Stock Market Holidays & Hours After Hours Trading Portfolio Management Cryptocurrency Dividend Investing Portfolio Strategy Fixed Income Retirement IPO's Podcasts Video Hub Editors' Picks Stock Analysis Stock Ideas Long Ideas Stock Upgrades & Downgrades Editors' Picks Quick Picks & Lists Emerging Markets ...
A break below this key level could portend further technical downside for the stock, which is currently trading on heavy volume with 4.8 million shares changing hand, well ahead of its three month daily average of 3.7 million shares.
公司简介阿比奥梅德公司于1981年在特拉华州注册成立。Abiomed公司是一家行业领先的机械循环支持设备供应商,,它能为心脏衰竭患者提供持续护理。公司开发、生产并销售的专利产品,是通过改善血液流动或执行心脏的泵血功能,让心脏休息、愈合并恢复。公司产品主要在心导管实验室使用,在外科医生做心脏手术需要血流动力支持前使用...
43828.060 -86.060-0.20% 收盘价 12/13 16:00 (美东) 44054.230最高价43790.480最低价 43929.150今开43914.120昨收4.55亿股成交量45073.63052周最高13上涨0.60%振幅37122.95052周最低17下跌43922.355平均价--平盘 概览期权资讯评论 分时 5日 日K 周K 月K ...
道琼斯指数即使在利率削减的期望下也无法摆脱联合健康的困扰。 TipRanks03:02 美股早市 | 三大指数集体走高,博通飙升近9%,特斯拉、谷歌双双创历史新高;加密货币概念股强势上扬,MARA涨近7%,Coinbase涨近4% 新浪财经12/16 23:26 美国CEO们游说“放弃关税”,但特朗普不听劝 华尔街见闻12/16 23:20 美国服务业强势...
Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push "The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato. JNJ Investing News, Analysis, and Tips...